PATENT CLAIM ANALYSIS

Application Number: 15887825
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "046000"]

Abstract:
The disclosure provides a method of treating chronic cough in a subject having idiopathic pulmonary fibrosis (IPF) comprising administering to the subject a pharmaceutical composition comprising from about 2% by weight to about 6% by weight of cromolyn sodium and an ionic osmotic agent with a nebulizer.

Claim (Index 17):
The method of  claim 16 , wherein the pharmaceutical composition comprises about 2% by weight of cromolyn sodium.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 88.0
- Lexical Diversity: 1.26829
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15887830', '15750811', '15750809', '14686535', '15621857']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7864615406732837
- 35 USC 102 Novelty (BERT): 0.6672057780386993
- Combined Prediction Score: 0.7745359644098253
- Mean Citation Score: 410.978096
- Max Citation Score: 719.5062
- Similarity Product: 611.3728051146984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test